Evidence map›Paper›PMID 26503922›Full record

ReviewNature reviews. Neurology2015

Neurology--the next 10 years.

Ralf Baron, Donna M Ferriero, Giovanni B Frisoni, Chetan Bettegowda, Ziya L Gokaslan, John A Kessler, Annamaria Vezzani, Stephen G Waxman, Sven Jarius, Brigitte Wildemann and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ralf BaronDivision of Neurological Pain Research and Therapy, Department of Neurology, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Arnold-Heller-Strasse 3, Haus 41, 24105 Kiel, Germany.
Donna M FerrieroDepartment of Pediatrics, University of California, San Francisco, 550 16th Street, Fourth Floor, San Francisco, CA 94158-2549, USA.
Giovanni B FrisoniMemory Clinic and LANVIE-Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Chemin du Petit Bel-Air 2 (Bâtiment Voirons), CH-1225 Chêne-Bourg, Genève, Switzerland.
Chetan BettegowdaThe Johns Hopkins University School of Medicine, Department of Neurosurgery, 600 North Wolfe Street, Baltimore, MD 21287, USA.
Ziya L GokaslanRhode Island Hospital, Department of Neurosurgery, Norman Prince Neurosciences Institute, 593 Eddy Street, APC 6, Providence, RI 02903, USA.
John A KesslerDepartment of Neurology, Feinberg School of Medicine, Northwestern University, 303 East Chicago Avenue, Chicago, IL 60611, USA.
Annamaria VezzaniDepartment of Neuroscience, Mario Negri Institute for Pharmacological Research, Via Giuseppe La Masa 19, 20156 Milan, Italy.
Stephen G WaxmanDepartment of Neurology, Yale University School of Medicine, PO Box 208018, New Haven, CT 06520, USA.
Sven JariusMolecular Neuroimmunology Group, Department of Neurology, Im Neuenheimer Feld 400, University of Heidelberg, 69120 Heidelberg, Germany.
Brigitte WildemannMolecular Neuroimmunology Group, Department of Neurology, Im Neuenheimer Feld 400, University of Heidelberg, 69120 Heidelberg, Germany.
Michael WellerDepartment of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the launch of our journal as Nature Clinical Practice Neurology in 2005, we have seen remarkable progress in many areas of neurology research, but what does the future hold? Will advances in basic research be translated into effective disease-modifying therapies, and will personalized medicine finally become a reality? For this special Viewpoint article, we invited a panel of Advisory Board members and other journal contributors to outline their research priorities and predictions in neurology for the next 10 years.

Indexed as

Alzheimer DiseaseAnimalsAutoantibodiesCentral Nervous System NeoplasmsChannelopathiesChildDemyelinating Autoimmune Diseases, CNSEpilepsyForecastingHumansNerve RegenerationNeurologyPediatricsAutoantibodies

Identifiers

PMID26503922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.